Sherlock Biosciences

The Future of Molecular Diagnostics

Watertown, United States · $299K raised

Employees
51–200
Business Model
B2B
Total Funding
$299K
Last Round
$299K GrantAug 2024
Rounds
1

About

Sherlock Biosciences develops CRISPR-based and synthetic biology diagnostic platforms for rapid, affordable molecular testing at the point of need. The company's proprietary SHERLOCK and INSPECTR platforms enable detection of DNA and RNA targets for applications including infectious disease, cancer, and STI testing. In 2020, Sherlock received the first FDA Emergency Use Authorization for a CRISPR-based diagnostic.

Summary

Sherlock Biosciences is a Biotech company based in Watertown, United States. It has raised $299K in total across 1 round, most recently a $299K Grant round in Aug 2024.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase I (NIH)Aug 2024
$299K

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sherlock Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/sherlock-biosciences"><img src="https://indexed.vc/api/badge/company/sherlock-biosciences" alt="Sherlock Biosciences on Indexed.vc" width="260" height="76" /></a>